Craig Coleman
Professor/Pharmacy Practice

Are you Craig Coleman?

How to update your information.
Scholarly Contributions

620 Scholarly Contributions

419
Journal Articles
137
Poster/Presentations
41
Other Scholarly Works
12
Digital and Electronic Media, Social Media, Blog, Podcast, Magazine/Trade Publications
6
Conference Proceedings
5
Book Chapters
Real-world evidence of stroke prevention in patients with non-valvular atrial fibrillation in the United States: the REVISIT-US study
2016
Craig Coleman
Research Type: Poster/Presentation

Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study.
2016
T Evers, R Cappato, K Bowrin, E P Simard, H Bonnemeier, Craig Coleman, M Antz
Research Type: Journal Article

Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS).
2017
Craig Coleman, M Antz
Research Type: Other Scholarly Work

Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study.
2021
S Danese, Craig Coleman, J Ulloa, P P Dobesh, B Lovelace
Research Type: Journal Article

Recombinant human growth hormone in the treatment of patients with cystic fibrosis.
2010
Jennifer E Girotto, Jennifer Scholle, R Talati, O J Phung, Craig Coleman, Erica L Baker, J Kluger, S S Makanji, Charles M White, Wei Chen
Research Type: Journal Article

Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status
2016
Craig Coleman
Research Type: Poster/Presentation

Reduction of Cardiac Arrests: The Experience of a Novel Service Centric Medical Emergency Team.
2015
D Madison, J Mather, T Madison, Craig Coleman, J Kluger, B Madison, J A Gluck, Ann Noyes
Research Type: Journal Article

Renin-angiotensin system inhibition for conversion of atrial fibrillation and maintenance of normal sinus rhythm: a meta-analysis.: 24.
2005
Charles M White, Craig Coleman, James Kalus
Research Type: Journal Article

Response to the Letter by Spurling and Colleagues.
2023
S J Connolly, M J Christoph-Schubel, Craig Coleman, J Beyer-Westendorf, B Lovelace, M Sharma, O S Costa
Research Type: Other Scholarly Work

Rivaroxaban Versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism: A Head-to-Head Analysis of the United States Cohort of the Observational Study in Cancer …
2022
Craig Coleman
Research Type: Poster/Presentation

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program.
2023
G Brobert, C Becattini, B Schaefer, Craig Coleman, K Abdelgawwad, M Carrier, A A Khorana, K S Caroti, G Psaroudakis, C Brescia, A Ekbom, M Rivera, A T Cohen
Research Type: Journal Article

Rivaroxaban Versus Warfarin and Renal Outcomes in Non-valvular Atrial Fibrillation Patients with Diabetes.
2019
Craig Coleman, A Fratoni, Adrian V Hernandez Diaz, D Eriksson, Thomas Bunz, Y M Roman, A Gasparini, Mohammad M Khan, G Bradley, A K Meinecke
Research Type: Journal Article

Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.
2018
J N Kjældgaard, P B Nielsen, T B Larsen, F Skj√∏th, Craig Coleman, M S√∏gaard
Research Type: Journal Article

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis.
2020
Thomas Bunz, V Ashton, O S Costa, J Beyer-Westendorf, K T Moore, D Milentijevic, Craig Coleman
Research Type: Journal Article

Rivaroxaban Versus Warfarin for Treatment and Prevention of Recurrent Venous Thromboembolism in Obese Patients
2020
Craig Coleman
Research Type: Poster/Presentation

Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
2020
Thomas Bunz, V Ashton, S Thompson, Craig Coleman, M Palladino
Research Type: Journal Article

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
2019
N A Sood, A K Meinecke, Craig Coleman, William L Baker Jr., D Eriksson, R Kreutz, Thomas Bunz
Research Type: Journal Article

Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice.
2016
A J Camm, S Tamayo, J Beyer-Westendorf, Craig Coleman
Research Type: Journal Article

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.
2023
K S Caroti, B Schaefer, K Abdelgawwad, A T Cohen, M Carrier, C Brescia, A A Khorana, M Rivera, Craig Coleman, C Becattini, G Psaroudakis, A Ekbom, G Brobert
Research Type: Journal Article

Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
2016
G J Fermann, C Crivera, E R Weeda, J R Schein, Craig Coleman, W F Peacock, C G Kohn
Research Type: Journal Article